{"result":[{"lastName":"Stockerl-Goldstein","clinicalFocus":[],"appointments":[{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Member,Cancer Center","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4547&type=small&showNoImage","displayName":"Keith Stockerl-Goldstein, M.D.","firstName":"Keith","href":"http://med.stanford.edu/profiles/cancer/researcher/Keith_Stockerl-Goldstein","researchInterest":"Clinical investigation of bone marrow and peripheral blood progenitor cell transplantation for lymphoproliferative disease and solid tumors; immunotherapy following high-dose therapy and transplantation; supportive care following transplantation; immune system reconstitution."},{"lastName":"Blume","clinicalFocus":[],"appointments":[{"appointment":"Emeritus (Active) Professor,Medicine - Division: Blood and  \r\nMarrow Transplantation"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Emeritus (Active) Professor,Medicine - Division: Blood and  \r\nMarrow Transplantation","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4180&type=small&showNoImage","displayName":"Karl Blume","firstName":"Karl","href":"http://med.stanford.edu/profiles/cancer/researcher/Karl_Blume","researchInterest":"Allogeneic and autologous bone marrow transplantation (experimental and clinical) as a treatment modality for leukemia, lymphoma, Hodgkin's disease, multiple myeloma, hereditary disorders, immune defects and selective solid tumors. Development of novel preparatory regimens to prevent the recurrence of the underlying malignancies. Studies for the prevention of acute and chronic graft-versus-host disease. Testing of new anti-viral agents to prevent or treat viral infections."},{"lastName":"Negrin","clinicalFocus":[{"focus":"Blood and Marrow Transplantation"},{"focus":"Hematology"}],"appointments":[{"appointment":"Professor,Medicine - Division: Blood and  \r\nMarrow Transplantation"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Professor,Medicine - Division: Blood and  \r\nMarrow Transplantation","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4138&type=small&showNoImage","displayName":"Robert Negrin","firstName":"Robert","href":"http://med.stanford.edu/profiles/cancer/researcher/Robert_Negrin","researchInterest":"Our labaratory focuses on the study of immune recognition by T and NK cells with special emphasis on graft vs host disease and graft vs tumor reactions. We utilize both murine and human systems in an effort to enhance graft vs tumor reactions while controlling graft vs host disease. We have developed bioluminescence models in collaboration with the Contag laboratory to study the trafficking of immune effector cells with a special emphasis on NK, T and regulatory T cells."},{"lastName":"Warnke","clinicalFocus":[{"focus":"Anatomic/Clinical Pathology"},{"focus":"Pathology and Laboratory Medicine"}],"appointments":[{"appointment":"Professor,Pathology"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Professor,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3786&type=small&showNoImage","displayName":"Roger Warnke","firstName":"Roger","href":"http://med.stanford.edu/profiles/cancer/researcher/Roger_Warnke","researchInterest":"The research in my laboratory involves the application of monoclonal and polyclonal antibodies and a variety of immunohistochemical methods to study human B-cell, T-cell, accessory cell and related neoplasms."},{"lastName":"Arber","clinicalFocus":[{"focus":"Anatomic/Clinical Pathology"},{"focus":"Pathology and Laboratory Medicine"}],"appointments":[{"appointment":"Professor - Med Center Line,Pathology"}],"primaryAppointment":"Professor - Med Center Line,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3925&type=small&showNoImage","displayName":"Daniel A. Arber, M.D.","firstName":"Daniel","href":"http://med.stanford.edu/profiles/cancer/researcher/Daniel_Arber","researchInterest":"I study molecular genetic and immunophenotypic changes in human hematopoietic neoplasms. These include acute and chronic leukemias, lymphoma, and splenic tumors."},{"lastName":"Advani","clinicalFocus":[{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Hematology"},{"focus":"Burkitt's Lymphoma - Medical Oncology"},{"focus":"Hodgkin's Disease"},{"focus":"Investigational Therapeutics"},{"focus":"Leptommeningeal Disease"},{"focus":"Lymphoma "},{"focus":"Mycosis Fungoides"},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Oncology"},{"focus":"Oncology (Cancer)"},{"focus":"Plasmacytoma"},{"focus":"Waldenstrom's Macroglobulinemia "}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4018&type=small&showNoImage","displayName":"Ranjana Advani","firstName":"Ranjana","href":"http://med.stanford.edu/profiles/cancer/researcher/Ranjana_Advani","researchInterest":"Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas.  Experimental therapeutics with novel chemotherapy and biologically targeted therapies.\r\n\r\nThe research program is highly collaborative with radiation oncology, industry, pathology and dermatology."},{"lastName":"Laport","clinicalFocus":[{"focus":"Blood and Marrow Transplantation"},{"focus":"Hematology"},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Division: Blood and  \r\nMarrow Transplantation"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Division: Blood and  \r\nMarrow Transplantation","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4546&type=small&showNoImage","displayName":"Ginna G. Laport","firstName":"Ginna","href":"http://med.stanford.edu/profiles/cancer/researcher/Ginna_Laport","researchInterest":"haploidentical transplantation, follicular lymphoma, adoptive immunotherapy,supportive care"},{"lastName":"Link","clinicalFocus":[{"focus":"Hematology/Oncology/Stem Cell Transplant,  Pediatric"},{"focus":"Pediatric Hematology-Oncology"}],"appointments":[{"appointment":"Professor,Pediatrics - Hematology/Oncology"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Professor,Pediatrics - Hematology/Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4631&type=small&showNoImage","displayName":"Michael Link","firstName":"Michael","href":"http://med.stanford.edu/profiles/cancer/researcher/Michael_Link","researchInterest":"Hematology/Oncology, treatment of sarcomas of bone and soft tissue, biology of acute lymphoblastic leukemias, treatment of non-Hodgkin's lymphoma and Hodgkin's disease."},{"lastName":"Rosenberg","clinicalFocus":[{"focus":"Hodgkin's Disease"},{"focus":"Hodgkin's Disease - Hematology"},{"focus":"Hodgkin's Disease - Medical Oncology"},{"focus":"Lymphoma "},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Emeritus (Active) Professor,Medicine - Oncology"},{"appointment":"Emeritus Faculty, Acad Council,Medicine - Oncology"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Emeritus (Active) Professor,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4127&type=small&showNoImage","displayName":"Saul A Rosenberg","firstName":"Saul","href":"http://med.stanford.edu/profiles/cancer/researcher/Saul_Rosenberg","researchInterest":"Clinical Interests: Hodgkin's disease and non-Hodgkin's lymphomas Research Interests: clinical trials, clinical-pathological-biological correlations"},{"lastName":"Dorfman","clinicalFocus":[],"appointments":[{"appointment":"Emeritus Faculty, Acad Council,Pathology"}],"primaryAppointment":"Emeritus Faculty, Acad Council,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6365&type=small&showNoImage","displayName":"Ronald Dorfman","firstName":"Ronald","href":"http://med.stanford.edu/profiles/cancer/researcher/Ronald_Dorfman","researchInterest":""},{"lastName":"Natkunam","clinicalFocus":[{"focus":"Hematopathology"},{"focus":"Pathology and Laboratory Medicine"},{"focus":"Anatomic/Clinical Pathology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Pathology"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Associate Professor - Med Center Line,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=5929&type=small&showNoImage","displayName":"Yasodha Natkunam, M.D., Ph.D","firstName":"Yasodha","href":"http://med.stanford.edu/profiles/cancer/researcher/Yasodha_Natkunam","researchInterest":"My research interests focus on the identification and characterization of markers of diagnostic and prognostic importance in hematolymphoid neoplasia."},{"lastName":"Levy","clinicalFocus":[{"focus":"Lymphoma "},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Non-Hodgkin's Lymphoma - Medical Oncology"},{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Medical Oncology"},{"focus":"Hodgkin's Disease"},{"focus":"Hodgkin's Disease - Medical Oncology"},{"focus":"Burkitt's Lymphoma - Hematology"},{"focus":"Hodgkin's Disease - Hematology"},{"focus":"Oncology"},{"focus":"Oncology (Cancer)"},{"focus":"Non-Hodgkin's Lymphoma - Hematology"}],"appointments":[{"appointment":"Professor,Medicine - Oncology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Professor,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4608&type=small&showNoImage","displayName":"Ronald Levy, MD","firstName":"Ronald","href":"http://med.stanford.edu/profiles/cancer/researcher/Ronald_Levy","researchInterest":"Clinical Interests: lymphoma. Research Interests: Immunology and molecular biology of lymphoid malignancy; molecular vaccines for cancer."},{"lastName":"Amylon","clinicalFocus":[{"focus":"Pediatric Hematology-Oncology"},{"focus":"Ped Hematology/Oncology"}],"appointments":[{"appointment":"Emeritus (Active) Professor,Pediatrics - Stem Cell Transplantation"}],"primaryAppointment":"Emeritus (Active) Professor,Pediatrics - Stem Cell Transplantation","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6097&type=small&showNoImage","displayName":"Michael Amylon","firstName":"Michael","href":"http://med.stanford.edu/profiles/cancer/researcher/Michael_Amylon","researchInterest":"Bone marrow transplantation (BMT) is a treatment modality which is being broadly applied to a growing number of disorders. Increasing success with BMT is offering improved survival to pediatric and adult patients with acute leukemia, chronic leukemia, lymphomas, and a variety of solid tumors as well as severe aplastic anemia."},{"lastName":"Donaldson","clinicalFocus":[{"focus":"Basal / Squamous Cell Carcinomas - Radiation Oncology"},{"focus":"Bone Cancer"},{"focus":"Brain / Central Nervous System Tumors"},{"focus":"Brain / Central Nervous System Tumors - Radiation Oncology"},{"focus":"Breast Cancer"},{"focus":"Breast Cancer - Radiation Oncology"},{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Radiation Oncology"},{"focus":"Childhood Cancers"},{"focus":"Eye / Orbital Cancer"},{"focus":"Eye / Orbital Cancer - Benign"},{"focus":"Eye / Orbital Cancer - Malignancies"},{"focus":"Germ Cell Tumors"},{"focus":"Germ Cell Tumors - Radiation Oncology"},{"focus":"Hodgkin's Disease"},{"focus":"Hodgkin's Disease - Radiation Oncology"},{"focus":"Leukemia"},{"focus":"Leukemia - Radiation Oncology"},{"focus":"Lymphoma "},{"focus":"Melanoma"},{"focus":"Melanoma - Radiation Oncology"},{"focus":"Multiple Myeloma"},{"focus":"Multiple Myeloma - Radiation Oncology"},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Non-Hodgkin's Lymphoma - Radiation Oncology"},{"focus":"Osteosarcoma "},{"focus":"Pediatric Cancers"},{"focus":"Pigmented Skin Lesions"},{"focus":"Pigmented Skin Lesions - Radiation Oncology"},{"focus":"Pituitary Adenomas"},{"focus":"Pituitary Adenomas - Radiation Oncology"},{"focus":"Radiation Oncology"},{"focus":"Sarcomas - Bone "},{"focus":"Sarcomas - Bone - Radiation Oncology"},{"focus":"Sarcomas - Radiation Oncology"},{"focus":"Sarcomas - Soft Tissue "},{"focus":"Sarcomas - Soft Tissue - Radiation Oncology"},{"focus":"Skin Cancer "},{"focus":"Skin Cancer - Radiation Oncology"},{"focus":"Therapeutic Radiology"},{"focus":"Thyroid Cancers"},{"focus":"Thyroid Cancers - Radiation Oncology  "}],"appointments":[{"appointment":"Professor,Radiation Oncology - Radiation Therapy"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Professor,Radiation Oncology - Radiation Therapy","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4098&type=small&showNoImage","displayName":"Sarah S. Donaldson, M.D.","firstName":"Sarah","href":"http://med.stanford.edu/profiles/cancer/researcher/Sarah_Donaldson","researchInterest":"Combined Modality Treatment of Cancer\r\nLate Effects of Treatment\r\nGenetic Effects of Cancer\r\nRhabdomyosarcoma\r\nHodgkins Disease\r\nPediatric Radiation Oncolgy\r\nPediatric Oncolgy\r\nBreast Cancer\r\nConformal Radiotherapy/IMRT\r\nRadiotherapy for Benign Diseases"},{"lastName":"Hancock","clinicalFocus":[{"focus":"Therapeutic Radiology"},{"focus":"CNS Cancers"},{"focus":"Lymphomas"},{"focus":"Prostate Cancer"},{"focus":"Radiation Therapy"}],"appointments":[{"appointment":"Professor - Med Center Line,Radiation Oncology - Radiation Therapy"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Professor - Med Center Line,Radiation Oncology - Radiation Therapy","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4626&type=small&showNoImage","displayName":"Steven Hancock","firstName":"Steven","href":"http://med.stanford.edu/profiles/cancer/researcher/Steven_Hancock","researchInterest":"Clinical research interests in the late effects of radiation on normal tissues and chemical modification of radiation injury. Hodgkins's disease and late effects of radiation and combined modality therapy. Radiation sensitizers. Hypoxic cell cytotoxins. Esophageal cancers.\r\nGeneral adult and pediatric radiation therapy."},{"lastName":"Johnston","clinicalFocus":[{"focus":"BMT"},{"focus":"Blood and Marrow Transplantation"},{"focus":"Hematology"},{"focus":"Graft-Versus-Host Disease"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Division: Blood and  \r\nMarrow Transplantation"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Division: Blood and  \r\nMarrow Transplantation","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4572&type=small&showNoImage","displayName":"Laura Johnston","firstName":"Laura","href":"http://med.stanford.edu/profiles/cancer/researcher/Laura_Johnston","researchInterest":"Clinical research in allogeneic and autologous hematopoietic cell transplantation (HCT), more specifically, allogeneic transplantation and graft versus host disease. Exploring methods of improving prevention and treatment of GVHD as well as the long term follow-up and/or quality of life of affected patients."},{"lastName":"Knox","clinicalFocus":[{"focus":"Radiation Oncology"},{"focus":"Radiation Therapy"}],"appointments":[{"appointment":"Associate Professor,Radiation Oncology - Radiation Therapy"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Associate Professor,Radiation Oncology - Radiation Therapy","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4699&type=small&showNoImage","displayName":"Susan Knox","firstName":"Susan","href":"http://med.stanford.edu/profiles/cancer/researcher/Susan_Knox","researchInterest":"Our interests in clude 1) study of the effect of radiation on regulatory cell subpopulations and co-stimulatory molecules, 2) use of radiation as an immune modulator for optimization of transplant regimens, and 3) the role of radiation in tumor vaccine strategies."},{"lastName":"Higgins","clinicalFocus":[{"focus":"Pathology and Laboratory Medicine"},{"focus":"Anatomic/Clinical Pathology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Pathology"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Associate Professor - Med Center Line,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4038&type=small&showNoImage","displayName":"John Higgins","firstName":"John","href":"http://med.stanford.edu/profiles/cancer/researcher/John_Higgins","researchInterest":"I work as a diagnostic surgical pathologist doing tissue and cDNA microarray-based translational research in renal neoplasia and medical renal disease. Subspecialty areas of clinical interest include diagnostic immunohistochemistry, renal, hepatic and transplant pathology."},{"lastName":"Ganjoo","clinicalFocus":[{"focus":"Hodgkin's Disease"},{"focus":"Hodgkin's Disease - Hematology"},{"focus":"Hodgkin's Disease - Medical Oncology"},{"focus":"Lymphoma "},{"focus":"Oncology"},{"focus":"Oncology (Cancer)"},{"focus":"Sarcomas - Soft Tissue "}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6696&type=small&showNoImage","displayName":"Kristen Ganjoo","firstName":"Kristen","href":"http://med.stanford.edu/profiles/cancer/researcher/Kristen_Ganjoo","researchInterest":"Non-Hodgkin's Lymphoma;\r\nSoft tissue sarcoma;\r\nOsteosarcoma."},{"lastName":"Cornbleet","clinicalFocus":[{"focus":"Pathology and Laboratory Medicine"},{"focus":"Anatomic/Clinical Pathology"}],"appointments":[{"appointment":"Emeritus (Active) Associate Professor,Pathology"}],"primaryAppointment":"Emeritus (Active) Associate Professor,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4109&type=small&showNoImage","displayName":"Phyllis Cornbleet","firstName":"Phyllis","href":"http://med.stanford.edu/profiles/cancer/researcher/Phyllis_Cornbleet","researchInterest":"As medical director of the Hematology Laboratory, my main focus is service work, including laboratory administration, bone marrow pathology, and flow cytometry interpretation. Publications arise primarily from development or evaluation of laboratory methods or collections of unusual patient cases."},{"lastName":"Cleary","clinicalFocus":[],"appointments":[{"appointment":"Professor,Pathology"},{"appointment":"Member,Cancer Center"},{"appointment":"Professor,Pediatrics"}],"primaryAppointment":"Professor,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4506&type=small&showNoImage","displayName":"Michael Cleary","firstName":"Michael","href":"http://med.stanford.edu/profiles/cancer/researcher/Michael_Cleary","researchInterest":"The role of oncoproteins in cancer and development; molecular and cellular biology of hematologic malignancies; targeted molecular therapies of cancer."},{"lastName":"Alizadeh","clinicalFocus":[],"appointments":[{"appointment":"Instructor,Medicine - Oncology"}],"primaryAppointment":"Instructor,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=9558&type=small&showNoImage","displayName":"Ash A. Alizadeh, MD/PhD","firstName":"Arash","href":"http://med.stanford.edu/profiles/cancer/researcher/Arash_Alizadeh","researchInterest":"My research is focused on attaining a better understanding of the initiation, maintenance, and progression of lymphoid tumors, and their response to immunochemotherapy toward improving current treatment strategies.  \r\n\r\nIn this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.  I hope to apply this knowledge towards the design of clinical trials in the treatment of patients with lymphoma, leukemia, and myeloma."},{"lastName":"Dahl","clinicalFocus":[{"focus":"Hematology/Oncology/Stem Cell Transplant,  Pediatric"},{"focus":"Oncology (Cancer), Pediatric"},{"focus":"Pediatric Hematology-Oncology"}],"appointments":[{"appointment":"Professor - Med Center Line,Pediatrics - Hematology/Oncology"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Professor - Med Center Line,Pediatrics - Hematology/Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4306&type=small&showNoImage","displayName":"Gary Dahl","firstName":"Gary","href":"http://med.stanford.edu/profiles/cancer/researcher/Gary_Dahl","researchInterest":"Hematology/Oncology, Phase I drug studies for childhood cancer, overcoming multidrug resistance in leukemia and solid tumors, biology and treatment of acute nonlymphocytic leukemia, early detection of central nervous system leukemia by measuring growth, factor binding proteins."},{"lastName":"Sikic","clinicalFocus":[{"focus":"Medical Oncology"},{"focus":"New Drug Studies"}],"appointments":[{"appointment":"Professor,Medicine - Oncology"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Professor,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4131&type=small&showNoImage","displayName":"Branimir I. Sikic, M. D.","firstName":"Branimir","href":"http://med.stanford.edu/profiles/cancer/researcher/Branimir_Sikic","researchInterest":"Research Interests: cancer pharmacology, mechanisms of resistance to anticancer drugs, regulation and function of MDR1 and tubulin genes, clinical trials of modulation of drug resistance, general oncology, Phase I trials of new drugs, gene expression profiling of cancers"},{"lastName":"Lowsky","clinicalFocus":[{"focus":"Blood and Marrow Transplantation"},{"focus":"Hematology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Division: Blood and  \r\nMarrow Transplantation"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Division: Blood and  \r\nMarrow Transplantation","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3811&type=small&showNoImage","displayName":"Robert Lowsky","firstName":"Robert","href":"http://med.stanford.edu/profiles/cancer/researcher/Robert_Lowsky","researchInterest":"Dr. Lowsky's research is focused on understanding the role of regulatory T cells in the prevention of GVHD and in promoting immune tolerance following organ transplantation."}]}